Lupin receives 3 observations on completion of USFDA inspection of Tarapur facility

Capital Market

Last Updated : Sep 23 2019 | 9:31 AM IST

Lupin announced the completion of the United States Food and Drug Administration (USFDA) inspection carried out at its Tarapur manufacturing (API) facility. The inspection was carried out between 16 September to 20 September 2019.

The inspection at the Tarapur facility closed with three observations. The Company is confident of addressing them satisfactorily.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Connect with us on WhatsApp

Board of Rudra Global Infra Products approves issue of 10 lakh equity shares on preferential basis

Karnataka Bank's Chairman gets elected as Chairman of governing board of Southern India Banks' Staff Training College

Central Bank of India to raise Tier II capital up to Rs 1000 crore

Paisalo Digital and Bank of Maharashtra sign co-origination of loan agreement

First Published: Sep 23 2019 | 9:14 AM IST

Lupin receives 3 observations on completion of USFDA inspection of Tarapur facility

More From This Section

Board of Rudra Global Infra Products approves issue of 10 lakh equity shares on preferential basis

Karnataka Bank's Chairman gets elected as Chairman of governing board of Southern India Banks' Staff Training College

Central Bank of India to raise Tier II capital up to Rs 1000 crore

Paisalo Digital and Bank of Maharashtra sign co-origination of loan agreement

Explore News